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Abstract ExpressionofHSV-1genesleadstotheinduction
of apoptosis in human epithelial HEp-2 cells but the subse-
quent synthesis of infected cell protein prevents the process
fromkillingthecells.Thus,virusesunabletoproduceappro-
priate prevention factors are apoptotic. We now report that
the addition of either a pancaspase inhibitor or caspase-9-
speciﬁc inhibitor prevented cells infected with an apoptotic
HSV-1 virus from undergoing cell death. This result indi-
cated that HSV-1-dependent apoptosis proceeds through the
mitochondrial apoptotic pathway. However, the pancaspase
inhibitordidnotpreventthereleaseofcytochromecfrommi-
tochondria, implying that caspase activation is not required
for this induction of cytochrome c release by HSV-1. The
release of cytochrome c was ﬁrst detected at 9 hpi while
caspase-9, caspase-3 and PARP processing were detected
at 12 hpi. Finally, Bax accumulated at mitochondria dur-
ing apoptotic, but not wild type HSV-1 infection. Together,
these ﬁndings indicate that HSV-1 blocks apoptosis by pre-
cluding mitochondrial cytochrome c release in a caspase-
independent manner and suggest Bax as a target in infected
human epithelial cells.
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Introduction
Apoptosisorprogrammedcelldeathisatightlyregulated,ir-
reversible process usually resulting in the demise of the cell.
This process is activated during normal development and
by diverse stimuli that disturb cell metabolism and physiol-
ogy [1]. Cells undergoing apoptosis show classical morpho-
logical changes which include membrane blebbing, nuclear
and cytoplasmic condensation, and endonucleosomal DNA
cleavage[2].Therearetwomajorroutesthroughwhichapop-
tosis is triggered {reviewed in [3]}. The ﬁrst, the intrinsic
pathway, involves the mitochondria. When this pathway is
triggered, cytochrome c is released from the mitochondria
into the cytoplasm where it associates with the apoptosis
protease-activating factor 1 (Apaf-1), allowing the recruit-
ment of the initiator caspase-9 to form the apoptosome. This
series of events leads to the direct activation of caspase-
9[ 4, 5]. The second, extrinsic, pathway involves signaling
through death receptors such as that for tumor necrosis fac-
tor or Fas ligand. Signaling through death receptors results
in the assembly of the death-inducing signaling complex
(DISC)withrecruitmentofthepro-formofinitiatorcaspase-
8throughadaptordeathdomain-containingproteins,leading
to activation of the procaspase by autoproteolysis. Finally,
both pathways converge at the activation of downstream ef-
fectorcaspases,suchascaspase-3{reviewedin[6]}.Insome
cases, the death receptor and mitochondrial pathways are in-
terconnected via the activation of the Bcl-2-family member
protein, Bid [7, 8], where caspase-8 cleaves Bid, generating
activatedtBidwhichtriggersthereleaseofcytochromec[9].
Apoptosis is also an important cellular response to virus
infection and many viruses, especially the large DNA
viruses, have evolved mechanisms to block the process from
killing infected cells {reviewed in [10]}. Recently, a large
body of information has been generated which describes
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apoptosis during herpes simplex virus 1 (HSV-1) infec-
tion {reviewed in [11]}. Brieﬂy, HSV-1 triggers apopto-
sis and then later infected cell proteins block the process
from killing the cell, thus modulating the cell death program
{reviewed in [12]}. While the induction of apoptosis by
HSV-1 occurs early and only IE gene expression is essential
for the viral induction process [13], the speciﬁc pathways
through which HSV-1-dependent apoptosis proceeds remain
unknown. HSV-1 activates the apoptotic program in a cell
type-dependent manner [14–16], and several groups have
demonstrated that HSV-1 has the ability to prevent apopto-
sis induced by diverse stimuli, such as staurosporine (STS)
[17], sorbitol-mediated osmotic shock [18], hyperthermia
and thermal shock [19], exposure to ceramide, tumor necro-
sis factor alpha (TNF-α), or anti-Fas antibody [14, 20], and
ethanol [21], as well as cytotoxic T lymphocytes [21]. Cel-
lular [22–24] and several viral gene products were shown
to play a role in preventing apoptosis induced by the virus.
The HSV-1 US3, gJ, and ICP6 proteins and LAT RNA are
capable of decreasing apoptosis induced by either virus in-
fectionorexposuretovariouschemicalstimuliintheabsence
of other viral functions [25–29]. Koyama and Adachi origi-
nallyshowedthatapoptosisoccurredduringwildtypeHSV-1
infectionwhendenovoproteinsynthesisisblocked[30].Ad-
ditionally, infection by replication-deﬁcient viruses deleted
forthegenesencodingeitherICP27[31]orICP4[32],which
donotmakelateviralproteins,resultsinapoptosisinsuscep-
tiblecelltypessuchasHEp-2[19,33,34].Thus,suchviruses
cantriggerbutnotpreventcelldeathandaretermedapoptotic
viruses [35]. Finally, it was shown that during the course of
HSV-1 infection, there is an apoptosis “prevention window”
between 3 and 6 h post infection (hpi) in which infected cell
antiapoptoticfactorsareproduced[12,17,35].However, the
exact process by which the virus manipulates the cell is not
known.
In this study, we examined the sequence of events that
occurs during HSV-1-dependent apoptosis. We show that
HSV-1 induced apoptosis through the apoptosome by trig-
gering the release of cytochrome c and the subsequent acti-
vation of caspase-9 in human epithelial HEp-2 cells. The
release of cytochrome c was ﬁrst detected at 9 hpi and
caspase-9, caspase-3 and PARP processing were detected
at 12 hpi. Viral infection performed in the presence of ei-
ther the pancaspase inhibitor z-VAD-fmk or the caspase-
9 speciﬁc inhibitor z-LEHD-fmk prevented cells infected
with apoptotic HSV-1 from undergoing cell death. How-
ever, the pancaspase inhibitor did not prevent the release
of cytochrome c, suggesting that caspase activation is not
required for the triggering of apoptosis by HSV-1. Finally,
Bax accumulated at mitochondria during apoptotic, but not
wild type HSV-1 infection. Together, these ﬁndings imply
that HSV-1 blocks apoptosis by targeting Bax and preclud-
ing mitochondrial cytochrome c release in human epithelial
cells.
Materials and methods
Cell lines and viruses
All cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) containing 5% fetal bovine serum. HEp-2
cells are human carcinoma cells which were obtained from
the American Type Culture Collection (Rockville, Md.).
HSV-1(KOS1.1) is the wild type parental virus of the repli-
cation deﬁcient virus HSV-1(vBS 27) ( 27) [31]u s e di n
this study. The infections were performed at 37◦C and all
comparative infections were done at the same multiplic-
ity of infection (MOI) of 5 or 10 plaque forming units
(PFU) per cell as indicated. These MOIs were high enough
to insure that virus was in excess compared to the num-
ber of cells, therefore assuring that 100% of the cells were
infected.
Pharmacological induction and inhibition of apoptosis
To induce apoptosis, HEp-2 cells were either infected with
the replication defective virus HSV-1(vBS 27) or treated
with chemical reagents for the times indicated. Apopto-
sis was chemically induce with either 10 µg/ml cyclo-
heximide (CHX, Sigma) and 10 ng/ml TNF-α (Sigma)
or 1 µM staurosporine (STS, Sigma). DNA strand breaks
were labeled with ﬂuorescein-conjugated dUTP using ter-
minal deoxynucleotide transferase (Boehringer Mannheim)
as recommended by the vendor and visualized by ﬂuo-
rescence microscopy (TUNEL) as described below. The
percentage of apoptotic cells was determined by count-
ing the number of TUNEL positive cells, dividing that by
the total number of cells (both TUNEL positive and nega-
tive), and multiplying by 100. Caspase inhibitors (z-VAD-
fmk, z-LEHD-fmk, z-DEVD-fmk, and z-LETD-fmk) were
obtained from Calbiochem and used at concentrations of
100 µM, as described [17]. In control studies, z-LEHD-
fmk and z-LETD-fmk at these concentrations blocked STS-
and TNF-α plus CHX-dependent apoptosis, respectively, as
expected.
Plasmid transfections
RecombinantplasmidpJB55containsapproximately2.3kbp
of HSV-1(F) genomic DNA cloned into pGEM3Z and ex-
presses ICP27 from its own promoter. pSVV-ORF4 con-
tains 1420 bp of the simian varicella virus (svv) genome
cloned into pCI-neo, expresses svv ICP27 (ORF 4) from
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its own promoter, and was generously provided for these
studies by R. Mahalingam (University of Colorado Health
Sciences Center) [36]. HEp-2 cells were transfected with
approximately 2.5 µg of plasmid DNA using the DOTAP
transfection reagent (Roche) as described previously [37].
Cell extract preparations, denaturing gel electrophoresis,
and transblotting
Cell cultures were harvested at the times post infection (p.i.)
or treatment indicated and whole infected cell extracts were
made as described previously [17]. Protein concentrations
were measured using a modiﬁed Bradford assay (BioRad)
as recommended by the vendor. Equal amounts of infected
cell proteins (50 µg) were separated in denaturing 15%
DATD-acrylamide gels and electrically transferred to nitro-
cellulose membranes in a tank apparatus (BioRad), prior
to immunoblotting with various primary antibodies. Unless
otherwise noted in the text, all biochemical reagents were
obtained from Sigma. Nitrocellulose membranes were ob-
tained directly from Schleicher and Schuell. Protein molec-
ular weight markers and all tissue culture reagents were pur-
chased from Life Technologies.
Immunological reagents
The following primary antibodies were used to detect vi-
ral proteins: (i) rabbit anti-thymidine kinase (TK) poly-
clonal antibody (gift of Bernard Roizman) (early protein
marker), (ii) H1119, mouse anti-ICP27 (immediate early
protein marker), (iii) H1114, mouse anti-ICP4 (immediate
early protein marker), (iv) RGST22, rabbit anti-ICP22 (im-
mediate early protein marker) [38] and (v) H1104, mouse
anti-glycoprotein C (gC) (late protein marker) monoclonal
antibodies (Goodwin Institute for Cancer Research, Plan-
tation, FL). Cellular proteins were detected using anti-
caspase-3 (Transduction Laboratories Inc.), anti-caspase-8
(clone B9-2), anti-caspase-9, anti-PARP, anti-cytochrome
c (clone 7H8.2C12) (Pharmingen), anti-Bcl-2 (sc-7382),
anti-Bax (sc-493), and anti-Bcl-XL (sc-634) (Santa Cruz
Biotechnology, Inc) antibodies. Anti-α-tubulin monoclonal
antibody (DM 1A, Sigma) was used to conﬁrm equal
loading of the cell extracts (data not shown). Secondary
(goat) anti-rabbit, anti-mouse and (rabbit) anti-goat an-
tibodies conjugated with alkaline phosphatase were pur-
chased from Southern Biotech (Birmingham, AL). Sec-
ondary (goat) anti-mouse and anti-rabbit antibodies conju-
gatedwithhorseradishperoxidasewereobtainedfromAmer-
sham.Fluoresceinisothiocyanate-conjugatedanti-rabbitIgG
heavypluslightchains(H+L),tetramethylrhodamineisoth-
iocyanate (Texas Red)-conjugated anti-rabbit IgG (H+L),
andTexasRed-conjugatedanti-mouseIgG(H+L)werepur-
chased from Vector Laboratories (Santa Cruz, Calif.) and
were used as secondary antibodies for indirect immunoﬂuo-
rescence.
Cytochrome c release assay
The protocol for detection of cytochrome c released into the
cytoplasm was an adaptation from that previously described
[39]. Brieﬂy, subconﬂuent cells in a 75 cm2 ﬂask (approx-
imately 6 × 107 cells) were either infected (MOI = 5)
or treated with STS for the times indicated in the text and
harvested by scrapping directly into the medium. The cells
weregentlypellettedbylowspeedcentrifugation(300 × g),
washed once in PBS, pelletted again, and resuspended in
100µlof10mMHEPES,pH7.4,50mMKCl,5mMEGTA,
5m MM g C l 2, 1 mM DTT, and 10% sucrose. Samples were
incubated on ice for 30 min, transferred to a Dounce ho-
mogenizer, and lysed by three strokes with a B type pestle.
The solution was transferred toa 1.5 ml tube and centrifuged
(300 × g) for 10 min at 25◦C. The supernatant was trans-
ferred to a fresh tube and frozen on crushed dry ice for
1 min, followed by high speed centrifugation (14,000 × g)
for 10 min to pellet the heavy membrane fraction and mi-
tochondria. The supernatant was removed and represented
the mitochondria-depleted cytoplasmic fraction which was
then immunoblotted for reactivity with anti-cytochrome c
antibody.
Indirect immunoﬂuorescence and microscopy
HEp-2 cell monolayers were grown on glass coverslips in
6-well dishes at 37◦C in DMEM with 5% fetal bovine serum
(FBS) and either infected (MOI = 5), treated with the apop-
tosis inducer, or both for the times indicated. Thirty minutes
prior to performing immunoﬂuorescence staining, the cells
were incubated in the presence of MitoTracker (Molecular
Probes) which was added to the medium at a ﬁnal concentra-
tion of 0.5 µM. At each time indicated, the cells were ﬁxed
with 2% (methanol free) paraformaldehyde in phosphate-
buffered saline (PBS) for 20 min and permeablized with
100% acetone at −20◦C for 4 min. Indirect immunoﬂu-
orescence staining was performed as described previously
[40]. Brieﬂy, the cells were incubated/blocked at 4◦Cf o r
at least 24 h in 1% BSA containing 10 µg/ml of pooled
human Ig (mainly IgG) (Sigma), prior to incubation with
primary antibody for 1 h. Then, a 45 min incubation was
performed with secondary antibody diluted in 1% BSA con-
taining5µg/mlHoechstDNAdye(Sigma).Finally,thecells
weremountedina0.1%Mowoil(Sigma)with2.5%DABCO
(Sigma) used as an antibleaching agent under a fresh cov-
erslip and sealed with nail polish. Cells were visualized on
either an Olympus IX70/IX-FLA inverted ﬂuorescence mi-
croscope or a Leica confocal laser-scanning microscope as
described [40]. The percentages of apoptotic cells also were
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determined by counting the number of cells with either cy-
tochrome c released from mitochondria or Bax translocated
to mitochondria, dividing those by the total number of cells,
and multiplying by 100.
Results
Herpes simplex virus 1 (HSV-1) modulates apoptosis dur-
ing productive infection in human epithelial cells. The goal
of this study is to deﬁne the cellular molecular mechanisms
through which this process occurs. We compare cellular re-
sponsestoinfectionbywildtypeviruswiththoseofanapop-
totic HSV-1 strain which triggers cell death but is unable to
prevent the process from killing the cells.
Caspase-9 is processed in HEp-2 cells infected
with a replication-defective, apoptotic HSV-1
Previously, we and others demonstrated that infection with
certainreplication-defective(apoptotic)HSV-1viruses,such
as those deleted for the regulatory ICP4 [19]o rI C P 2 7[ 33]
proteins, induce apoptosis in infected cells. While wild type
HSV-1 triggers the cell death program [21] and caspase-3
is activated during productive infection [17], subsequently
synthesized infected cell proteins act to inhibit the apop-
totic process [17]. The ﬁrst question we asked was whether
upstream (initiator) caspases were cleaved during HSV-1
infection. Two sets of experiments were performed. In the
ﬁrstseries,HEp-2cellsweremock-,HSV-1(KOS)-,orHSV-
1(vBS 27)-infected in the presence or absence of the pan-
caspase inhibitor z-VAD-fmk. At 18 hpi, cells were stained
withHoechstDNAdyeandprocessedwithTUNELreagents
(Fig. 1(A)) as described in Materials and Methods. Cells in-
fected with the replication-defective virus vBS 27 showed
classical apoptotic morphologies such as nuclear fragmenta-
tion and chromatin condensation, observed as bright, par-
titioned Hoechst staining of the nuclei. Additionally, all
the cells infected with vBS 27 were positive for TUNEL
staining, revealing the presence of cleaved genomic DNA
in those cells. However, cells infected with vBS 27 which
were treated with the pancaspase inhibitor z-VAD-fmk dur-
ing infection had no apoptotic morphologies or DNA frag-
mentation. Nearly all of the mock- and wild type KOS virus-
infected cells had uniformly stained nuclei with no sign
of condensation. These results demonstrate that the apop-
totic features observed in cells infected with the replication-
defective vBS 27 virus were dependent upon caspase ac-
tivities. A few of the KOS-infected cells showed Hoechst
staining characteristic of apoptotic cells. This represents
the earlier noted [17] minimal level of apoptosis associ-
ated with this particular virus strain due to the compet-
ing induction and prevention processes [11]. Interestingly,
certain KOS-infected cells had slight but detectable TUNEL
stainingwhichmayrepresentterminaltransferaselabelingof
replicating viral DNA. Importantly, vBS 27 does not syn-
thesize viral DNA in these cells [35]. It should be noted that
the vBS 27 repair virus (generated by the reintroduction
of the ICP27 gene into defective vBS 27) does not induce
any apoptotic morphologies seen with the vBS 27 deletion
virus [33]. Thus, all phenotypes associated with vBS 27
result solely from the absence of the ICP27 gene. In addi-
tion, earlier detailed studies from our laboratory showed that
a series of 10 different ICP27 mutant viruses induced the
same apoptotic phenotype as vBS 27 [35], indicating that
unlikely gain-of-function mutations elsewhere in the viral
genome are not the culprit.
In the second series of experiments, we performed
immunoblot analyses to determine whether induction of
caspase-8orcaspase-9wasinvolvedintheHSV-1-dependent
apoptosis process. HEp-2 cells were either mock-infected,
infectedwithvBS 27,orKOS-infectedwithandwithoutthe
protein synthesis inhibitor cycloheximide (CHX). As posi-
tivecontrolsforthedetectionofcaspase-9andcaspase-8pro-
cessing, mock-infected cells were treated with staurosporine
(STS) and TNF-α in the absence or presence of CHX. Cell
extracts were made at 24 h post infection or treatment and
immunoblot analyses (Fig. 1(B)) to detect caspase, as well
as PARP, processing were performed as described in Ma-
terial and Methods. In this system, anti-caspase-3, -8, and
-9 antibodies react with procaspase forms and loss of the
procaspase indicates cleavage.
Asexpected,completePARPcleavagewasdetectedinthe
control HEp-2 cells treated with either STS or TNF-α plus
CHX since the full length (116,000 mol wt) form of PARP
disappeared while the processed (85,000 mol wt) form was
detected (Fig. 1(B), lane 3 and 4). These cells had complete
loss of procaspase-3. Cells that were infected with vBS 27
or KOS in the presence of CHX also had signiﬁcant PARP
and procaspase-3 cleavage (lane 5 and 6). Procaspase-9 was
processed in the vBS 27 and KOS plus CHX cells while
KOSalonehadalevelsimilartomock(comparelane5and6
with7and8).Onlythemock-infectedcellstreatedwithTNF-
α plus CHX, showed signiﬁcant processing of procaspase-8
(lane 3). Together, these data suggest that HSV-1-induced
apoptosis proceeds through a caspase-9-dependent pathway.
Reduced apoptotic features in cells infected
with replication-defective vBS 27 in the presence
of caspase-9 inhibitor
The results above implicate caspase-9 in HSV-1-dependent
apoptosis. To determine whether caspase-9 processing was
a critical event in the induction of apoptosis by HSV-1, in-
fections were performed in the presence of various caspase
inhibitors. HEp-2 cells were mock-infected or infected with
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Fig. 1 Caspase-dependent apoptosis during vBS 27 infection of hu-
man epithelial cells. A. Addition of pancaspase inhibitor blocked apop-
tosis in vBS 27-infected cells. HEp-2 cells were uninfected (Mock)
or infected with wild type HSV-1(KOS) or replication-defective HSV-
1(vBS 27) (MOI = 10) for 18 h in the presence or absence of z-
VAD-fmk. Nuclei were visualized by ﬂuorescence following staining
with Hoechst or treatment with the TUNEL reagent and percentages of
apoptoticcellsweredeterminedasdescribedinMaterialsandMethods.
B. Complete activation of caspase-9 and caspase-3 during vBS 27
infection. Mock-, KOS-, and vBS 27-infected (MOI = 10) HEp-2
cell extracts were prepared at 24 hpi, separated in a denaturing gel,
transferred to nitrocellulose, and probed with anti-PARP, -caspase-8,
-caspase-9, and -caspase-3 antibodies as described in Materials and
Methods. CHX was added during wild type KOS infection to block the
synthesis of infected cell antiapoptotic factors. STS (1 µM) and TNF-α
(10 ng/ml) plus CHX (10 µg/ml) were added to mock-infected cells
as positive controls for apoptosis. 116 and 85 refer to the sizes in kDa
of unprocessed (116,000 mol. wt.) and processed PARP (85,000 mol.
wt.), respectively
vBS 27 or KOS and at 18 hpi, cell morphologies (Fig. 2)
were documented prior to preparing whole cell extractions
and immunoblotting against cellular death factor (Fig. 3(A))
and viral proteins (Fig. 3(B)), as described in Materials and
Methods. Immunoblotting analyses for representative viral
proteins were performed to determine whether the caspase
inhibitors had any negative effect on viral replication.
HEp-2 cells infected with wildtype KOS showed reduced
cell-cell contact and tended to round up (Fig. 2); this phe-
notype being deﬁned as the cytopathic effect (CPE) due to
viral replication. Cells infected with KOS in the presence
of each caspase inhibitor had similar CPEs to that observed
in the absence of caspase inhibitor. In contrast, the cells in-
fected with vBS 27 in the absence of any inhibitor showed
apoptotic morphologies including cell shrinkage and mem-
brane blebbing, as represented by smaller cell sizes with
irregular shapes/membranes. These morphologies were not
observed in vBS 27-infected cells when either the pan-
caspase (z-VAD-fmk) or caspase-9 (z-LEHD-fmk) inhibitor
was present during infection. These results, along with those
above (Fig. 1(A)), demonstrate that vBS 27-induced apop-
tosis is caspase-dependent. However, characteristic apop-
totic morphologies were still seen in vBS 27-infected cells
(Fig. 2) in the presence of caspase-3 and caspase-8 in-
hibitors. The apoptotic phenotype seen in the presence of the
caspase-3inhibitorcouldbetheresultofactivationofanother
Springer24 Apoptosis (2007) 12:19–35
Fig. 2 Speciﬁc inhibition of caspase-9 or caspase-3 but not caspase-8
prevents apoptosis during vBS 27 infection. HEp-2 cells were mock-,
HSV-1(KOS)-, and HSV-1(vBS 27)-infected (MOI = 5) in the ab-
sence or presence (100 µM) of pancaspase (zVAD-fmk), caspase-9 (z-
LEHD-fmk), caspase-3 (zDEVD-fmk), and caspase-8 (z-LETD-fmk)
inhibitors. Cell morphologies were observed by phase contrast mi-
croscopy at 18 hpi as described in Materials and Methods. (Magniﬁca-
tion, × 60)
Fig. 3 Speciﬁc inhibition of caspase-9 or caspase-3 prevents death
factor processing during vBS 27 infection. HEp-2 cells were mock
(M)-, HSV-1(KOS)-, and HSV-1(vBS 27)-infected (MOI = 5) in the
absence or presence (100 µM) of pancaspase (zVAD-fmk), caspase-
9 (z-LEHD-fmk), caspase-3 (zDEVD-fmk), and caspase-8 (z-LETD-
fmk) inhibitors. Infected cell extracts of the cell shown in Fig. 2 were
prepared at 18 hpi, separated in a denaturing gel, transferred to ni-
trocellulose, and probed with anti-PARP, -caspase-9, -caspase-8, and
-caspase-3 antibodies (A) as described in Material and Methods. B.
Viral protein accumulations. Immunoblotting was performed for viral
proteins using anti-ICP4, -gC, -ICP27, and -TK antibodies (B)
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downstream effector caspase, such as caspase-7 [41]. It has
recentlybeendemonstratedthatcaspase-3aswellascaspase-
7 are key mediators of mitochondrial events of apoptosis and
only the cells lacking both enzymes were highly resistant to
apoptosis [42].
The cells infected with vBS 27 in the presence of the
pancaspase inhibitor (z-VAD-fmk) showed a reduction in
PARP, procaspase-9, and procaspase-3 processing compared
to those in the absence of the inhibitor (Fig. 3(A), compare
lane 2 and 3). Among the vBS 27-infected cells treated
with speciﬁc caspase inhibitors, only those treated with
the caspase-9 (z-LEHD-fmk) inhibitor (Fig. 3(A), lane 4)
showedreducedPARPprocessingcomparedtotheuntreated,
infected cells (compare lane 2 with lane 4–6). It is interest to
notethatalthoughz-LETD-fmkdidnotblockPARPprocess-
i n gi nv B S  27-infected cells (lane 6), it appeared to reduce
caspase-3 cleavage (compare lane 6 with 2). While addition
of the pancaspase and caspase-9 inhibitors resulted in in-
creased detection of procaspase-9 (lane 3 and 4), inhibition
by z-LEHD-fmk was likely not complete since procaspase-3
was still mostly processed in its presence (lane 4). Another
explanation for the cleavage of procaspase-3 in the pres-
ence of z-LEHD-fmk could be that caspase-3 can be cleaved
by another initiation caspase at a lower level than that by
caspase-9. Regardless, these results indicate that caspase-9
is cleaved during vBS 27 infection.
Finally, the amounts of representative viral proteins re-
mained unchanged in the cells infected with KOS in the
presence of any caspase inhibitor, compared to their absence
(Fig. 3(B), compare lane 7 with 8–11). Little to no TK and
gC was detected in vBS 27-infected cells. This was ex-
pected as this virus, which possesses a deletion of the UL54
gene encoding ICP27, is defective in viral early and late
gene expression [31]. Consistent with previous results [35],
the level of immediate early ICP4 was slight, but detectable
(lane 2) and increased in the presence of the caspase-3 in-
hibitor (lane 5). In addition, an increased amount of ICP4
was also observed in vBS 27-infected cells in the presence
of the pancaspase, caspase-8, and caspase-9 inhibitors (com-
pare lane 2 with 3, 4, 6). ICP4 levels were higher in the
infected cells treated with any of the four caspase inhibitors
compared to the absence of inhibitors, but this was espe-
cially true with the pancaspase (z-VAD) or the caspase-9
(LEHD) inhibitor. Both inhibitors strongly prevent HSV-1
induced apoptosis and, hence, the early demise of the cells.
Therefore, the observed increase of the ICP4 levels likely
results from an absence of protein degradation as a result of
the dismantlement of the cells due to the induction of apop-
tosis. These ﬁndings indicate that caspase inhibition leads
to enhanced vBS 27 replication, as measured by viral pro-
tein accumulation. Together, these sets of data indicate that
caspase-9 plays an important role in the HSV-1-dependent
apoptosis induction process.
Cytochrome c release during HSV-1-dependent apoptosis is
independent of caspase activation
The ﬁnding that procaspase-9 is cleaved during vBS 27 in-
fectionimplicatestheintrinsicpathwayinHSV-1-dependent
apoptosis. Caspase-9 activation is usually the result of cy-
tochrome c being released from the mitochondria into the
cytoplasm [43]. Thus, our goal was to determine whether
cytochrome c was released in HSV-1-infected cells. HEp-
2 cells grown on coverslips were either mock-infected or
infected with vBS 27 or KOS for 18 h in the presence or
absenceofpancaspaseinhibitor(z-VAD-fmk),priortostain-
ing with anti-cytochrome c antibody, MitoTracker reagent,
and Hoechst as described in Material and Methods. In paral-
lel, mock-infected cells were treated with STS as a positive
control for cytochrome c release as this kinase inhibitor in-
duces cell death through the mitochondria [44]. Thus, when
apoptosis is triggered through the mitochondrial pathway,
cytochrome c is released from the mitochondria into the cy-
toplasm.
In mock-infected cells, cytochrome c showed punctuate
staining in the cytoplasm and perinuclear region which was
similartothatofthemitochondria(MitoTracker)(Fig.4(A)).
These results are consistent with a mitochondrial localiza-
tion of cytochrome c in healthy cells (only 3% apoptosis).
The cells treated with STS showed chromatin condensation
and nuclei fragmentation when stained with Hoechst. The
staining for cytochrome c in those cells was not punctate and
perinuclear but, rather, diffuse (96% apoptotic). In the cells
infected with the wild type KOS virus, the majority of the
cells had a staining pattern similar to that seen with mock-
infected cells (18% apoptotic), indicating that cytochrome
c was still localized in the mitochondria. In contrast, the
cells infected with the replication-defective vBS 27 virus
showed diffuse staining of cytochrome c, suggesting the re-
lease of the molecule into the cytoplasm (55% apoptotic).
When the intrinsic apoptotic cascade is triggered through
a mitochondrial pathway, cytochrome c release occurs prior
to the activation of caspase-9 and caspase-3 [43]. In an alter-
native pathway, activated caspase-8 cleaves Bid, leading to
cytochrome c release [7–9]. To differentiate between these
two pathways, we next determined whether cytochrome c
is released during HSV-1 infection in the absence of cas-
pase activation. In the presence of the pancaspase inhibitor
(z-VAD-fmk), all infected or treated cells showed uniform
staining of nuclei (Fig. 4(B)). This demonstrated that cas-
pase inhibition during either viral infection or STS treatment
prevented the cells from undergoing chromatin condensa-
tion and nuclear fragmentation. However, when the cells
were stained for cytochrome c, those infected with vBS 27
or treated with STS presented a diffuse staining pattern in
the presence of the inhibitor. In contrast, the majority of
the cells infected with KOS in the presence of z-VAD-fmk
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Fig. 4 Cytochrome c is released from mitochondria during
vBS 27 infection. HEp-2 cells were mock-, HSV-1(KOS)-, and HSV-
1(vBS 27)-infected (MOI = 5) in the absence (A)o rp r e s e n c e( B)o f
100 µM pancaspase (z-VAD-fmk) inhibitor. At 18 hpi, the cells were
ﬁxed, prepared for indirect immunoﬂuoresence using anti-cytochrome
c antibodies, and the number (%) of apoptotic cells were determined as
described in Material and Methods. DNA and mitochondria were de-
tected by ﬂuorescence microscopy following Hoechst and MitoTracker
(MitoT) staining, respectively. Magniﬁcation (×100)
showed punctate cytochrome c staining (Fig. 4(B)), simi-
lar to that observed in mock- or KOS-infected cells in the
absence of the caspase inhibitor (Fig. 4(A)). These data in-
dicate that the release of cytochrome c from mitochondria
in vBS 27-infected cells does not require caspase activa-
tion. In addition, active caspases are not required for wild
type HSV-1 to prevent the virus-dependent cytochrome c re-
lease. Taken together, our ﬁndings imply that cytochrome c
release during HSV-1-dependent apoptosis precedes caspase
activation.
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Cytochrome c release occurs prior to caspase-3, -9, and
PARP processing in vBS 27-infected cells
The results above indicated that cytochrome c release oc-
curred in the absence of caspase activation. The goal of this
series of experiments was to determine the kinetics of cy-
tochrome c release and death factor processing during HSV-
1-dependent apoptosis. Initially, cells were infected with
vBS 27 virus and ﬁxed at 3, 6, 9, and 12 hpi for indi-
rect immunoﬂuorescence using anti-cytochrome c antibody
along with Hoechst and MitoTracker staining. In a second
set of experiments, whole cell and mitochondria-depleted
cytoplasmic extracts of vBS 27-infected cells were made at
3, 6, 9, 12, 15, 18, and 24 hpi as described in Materials and
Methods and immunoblotted using anti-PARP, -caspase-3,
-caspase-9 and -cytochrome c antibodies. Controls included
mock- and KOS-infected cells, as well as STS-treated cells.
At 3 and 6 hpi, vBS 27-infected cells had punctate cy-
tochromecstainingattheperinuclearregionaswellasinthe
cytoplasm (1% apoptosis) (Fig. 5(A)). Diffuse cytochrome c
staining could be detected at 9 hpi in some of the vBS 27-
infected cells (29% apoptosis). At 12 hpi, approximately
half of the vBS 27-infected cells showed cytochrome c re-
lease (50% apoptosis). These ﬁndings suggest that apoptotic
triggering events prior to 9 hpi during vBS 27 infection
initiate a process leading to mitochondrial cytochrome c re-
lease. Consistent with the results above (Fig. 4), cytochrome
c release was detected in apoptotic, STS-treated cells (100%
apoptosis) but not in mock- or KOS-infected cells (< 1%
and 7% apoptosis, respectively) at 12 hpi (Fig. 5(B)).
Complete PARP processing was observed at 15, 18, and
24 hpi during vBS 27 infection (Fig. 6(A), lane 6–8). At
12 hpi (lane 5), processing of caspase-3 and 9 could be de-
tected and increased from this time to 24 hpi (lane 5–8).
While STS-treated cells had increased cytochrome c at 6 h
post treatment compared to mock in mitochondria-depleted
cytoplasmic extracts (Fig. 6(B), compare lane 12 with 11),
vBS 27-infected cells resembled mock at this time point
(comparelane2with1).IngeneralforvBS 27andSTS,in-
creased cytochrome c correlated with complete PARP cleav-
age (lane 3–5 and 12–15). As expected, little to no PARP
cleavage was observed with KOS at any time point (lane
7–10). However, we did observe increased cytochrome c re-
lease with KOS at 12–24 hpi. While this may represent the
levelofapoptosisobservedwithKOS(Figs.1–4),thisseems
unlikely because the extent of release observed by indirect
immunoﬂuorescence with KOS at 12 hpi was minimal (Fig.
4). Taking these results together with those of Fig. 5,w e
conclude that cytochrome c release occurs prior to caspase-
3, -9, and PARP processing in vBS 27-infected cells. These
experiments help determine points in the cellular apoptotic
pathways which are inhibited by wild type HSV-1. While it
appears that KOS infection may lead to the release of some
cytochrome c and cause some PARP to be cleaved, the bulk
of the proapoptotic machinery is inhibited.
Proapoptotic Bax targets mitochondria in vBS 27-infected
cells
The ﬁndings above imply that HSV-1-dependent apoptosis
observed during vBS 27 infection initiates by the release of
cytochrome c from mitochondria followed by the activation
of caspase-9 and -3, ultimately leading to complete PARP
processing as well as chromatin condensation, cell shrink-
age, and membrane blebbing. A key unanswered question
is at which step in this apoptotic process do cellular factors
produced during wild type HSV-1 infection act to inhibit the
pathway. Therefore, our goal in this study was to investi-
gate the behavior of certain Bcl-2 family members during
HSV-1 infection. Two sets of experiments were performed.
In the ﬁrst series, we focused on proapoptotic Bax which is
known to translocate to the mitochondria during most cases
ofapoptosiswhichareinducedthroughtheintrinsicpathway
[8, 9, 44, 45]. HEp-2 cells were mock-, KOS-, and vBS 27-
infected. At 6 and 18 hpi, cells were ﬁxed and prepared
for indirect immunoﬂuoresence using anti-Bax antibody, as
well as stained with Hoechst and MitoTracker as described
in Material and Methods. At 6 hpi, Bax was evenly dis-
tributed throughout all cells (Fig. 7(A)). At 18 hpi, several
vBS 27-infected cells had concentrated Bax staining ob-
served at mitochondria (33% apoptosis) compared to mock
or KOS (2% and 15% apoptosis, respectively) (Fig. 7(B)).
These ﬁndings suggest that wild type HSV-1 can block the
translocationofBaxtomitochondriawhilevBS 27cannot.
In the second series of experiments, the accumulations
of representative Bcl-2 family members were characterized
duringHSV-1infection.HEp-2cellswereinfectedwithKOS
or vBS 27-infected, whole cell extracts were prepared at 3,
6, 9, 12, and 24 hpi, separated in a denaturing gel, trans-
ferred to nitrocellulose, and probed with anti-Bcl-XL,- B c l -
2, -Bax, -PARP, -caspase-3, -ICP4, and -gC antibodies as
described in Materials and Methods. Consistent with our re-
sults above, KOS accumulated viral proteins (ICP4 and gC)
while vBS 27 did not (Fig. 8(C)) and procaspase-3 cleav-
age correlated with PARP processing in vBS 27-infected
cells (Fig. 8(B), lane 5–7). No obvious change in the levels
of Bax and Bcl-2 was detected with either vBS 27 or KOS
(Fig. 8(A)). Thus, the localization of Bax we observed above
(Fig. 7) with vBS 27 likely represents a translocation event
and not an increase in newly synthesized protein. While the
levels of antiapoptotic Bcl-XL also remained constant at 3–
12 hpi with vBS 27 and KOS (Fig. 8(A), lane 2–5 and
8–11), slight increases in the amounts of this protein were
detected at 16 and 24 hpi (lane 6, 7 and 12, 13). This was
somewhat surprising and its signiﬁcance remains unclear at
this time. Based on the results in Figs. 7 and 8, we conclude
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Fig. 5 Cytochrome c is
released from mitochondria at
early times during vBS 27
infection.
HSV-1(vBS 27)-infected
(MOI = 5) HEp-2 cells were
visualized at 3–12 hpi by
indirect immunoﬂuoresence
using anti-cytochrome c
antibody, phase contrast
microscopy, and ﬂuorescence
microscopy following Hoechst
and MitoTracker (Mitochondria)
staining. Control mock-,
HSV-1(KOS)-infected, and
STS-treated cells at 12 hpi are
shown. The number (%) of
apoptotic cells were determined
as described in Material and
Methods
that wild type HSV-1 blocks the caspase-9 apoptotic process
by preventing the translocation of proapoptotic Bax to mito-
chondria. We propose that infected cell factors are produced
by HSV-1 which facilitate this inhibition. During vBS 27
infection, these Bax-antagonizing factors are not produced
and the cell then dies by apoptosis.
ICP27 protein alone does not block apoptosis
Most of the experiments above consist of comparisons be-
tweenwildtypeHSV-1andanICP27-nullvirus.Twomodels
mightexplainwhyanHSV-1virusdeletedfortheICP27pro-
tein is able to induce but not prevent apoptosis. First, ICP27
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Fig. 6 A Caspase-9 activation leads to caspase-3 and PARP cleavage
during vBS 27 infection. Cytoplasmic extracts of HSV-1(vBS 27)-
infected (MOI = 10) and (1 µM) STS-treated HEp-2 cells were pre-
pared at 3–24 hpi, separated in a denaturing gel, transferred to nitrocel-
lulose,andprobedwithanti-PARP,caspase-9,andcaspase-3antibodies.
The location of caspase-9 is indicated. The fainter band above caspase-
9 was seen in all lanes and is likely attributable to nonspeciﬁc reactivity
of the antibody in this blot. Controls include mock (M)- and HSV-
1(KOS)-infected cells. B. Cytochrome c release from mitochondria
leads to caspase-3 activation and PARP cleavage during  27 infec-
tion. Cytoplasmic extracts of HSV-1(vBS 27)-infected (MOI = 10)
and (1 µM) STS-treated HEp-2 cells were prepared at 6–24 hpi, sepa-
rated in a denaturing gel, transferred to nitrocellulose, and probed with
anti-PARP, -cytochrome c(cyto. c.), and -caspase-3 antibodies. Control
mock-infected (M) cells at 24 hpi are shown
itself may directly inhibit apoptosis. Alternatively, ICP27
may regulate the expression of other viral or cellular fac-
tor(s) with antiapoptotic functions. The goal of this ﬁnal set
of experiments was to ascertain which scenario is correct.
Three sets of experiments were performed (Fig. 9). In the
ﬁrst set, HEp-2 cells were transfected with a plasmid ex-
pressing the HSV-1 ICP27 gene as described in Materials
and Methods. At 48 h post transfection, cells were treated
with STS, prior to anti-ICP27 antibody and Hoechst staining
and ﬂuorescence microscopy. The results (Fig. 9(A)) indi-
cate that even though cells express highly detectable levels
of ICP27, they still undergo chromatin condensation in re-
sponse to STS.
In the second set of experiments, plasmids containing the
HSV-1 ICP27 gene and the simian varicella virus ICP27
(svv27) gene were separately transfected into HEp-2 cells,
treated with STS, and whole cell extracts were immunoblot-
tedforreactivitywithanti-PARP,-ICP27,and-caspase-3an-
tibodies. As expected, the anti-ICP27 antibody reacted with
transfected HSV-1 ICP27 but not svv27 (Fig. 9(B), compare
lane 4, 5 with 7, 8). Transfections of ICP27 or svv27 into
the cells did not prevent PARP and procaspase-3 cleavage in
response to STS (lane4–6). Together, the resultsinFig.9(A)
and (B) indicate that sole expression of ICP27 in unable to
prevent environmentally induced apoptosis. Thus, it seems
unlikely that ICP27 alone would be sufﬁcient to generate an
antiapoptotic state.
In the ﬁnal set of experiments, HEp-2 cells were trans-
fected with the plasmid expressing ICP27 and at 48 h post
transfection, infected with vBS 27 (MOI = 5). At 6 hpi,
STS was added and the cells were incubated for an addi-
tional 12 h. Thus, at 18 hpi, the transfected/infected cells
were stained with Hoechst and visualized following indirect
immunoﬂuorescence using anti-ICP27 (transfection marker)
and -ICP22 (infection marker) antibodies. ICP22 is an im-
mediate early viral protein which was used as a marker for
infected cells. The results (Fig. 9(C)) indicate that infected
(red)ICP27expressing(green)cellsdidnotshowcondensed
chromatin features, while vBS 27 only infected cells (red,
no green) did. It should be noted that in HEp-2 cells, the
amount of ICP22 produced upon vBS 27 infection is much
lowerthanthatdetectedinwildtypevirusinfectedcells[33].
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Fig. 7 Bax localizes to mitochondria during vBS 27 infection. HEp-
2 cells were mock-, HSV-1(KOS)-, and HSV-1(vBS 27)-infected
(MOI = 5). At 6 A and 18 B hpi, cells were ﬁxed, prepared for
indirect immunoﬂuoresence using anti-Bax antibodies, and the num-
ber (%) of apoptotic cells were determined as described in Material
and Methods. DNA and mitochondria were detected by ﬂuorescence
microscopy following Hoechst and MitoTracker (MitoT) staining, re-
spectively. Magniﬁcation (×100)
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Fig. 8 Bcl-XL, Bcl-2, and Bax protein levels remain unchanged
throughout vBS 27 and KOS infection. Wild type HSV-1(KOS)- and
HSV(vBS 27)-infected (MOI = 10) HEp-2 cell extracts were pre-
pared at 3–24 hpi, separated in a denaturing gel, transferred to nitrocel-
lulose, and probed with anti-Bcl-XL, -Bcl-2, -Bax, -PARP, -caspase-3,
-ICP4, and -gC antibodies as described in Materialsand Methods. Con-
trol mock-infected (M) cells at 24 hpi are shown
Therefore, it was expected that the ICP22 signal is lower in
the infected cells not expressing ICP27 (red only). These
results indicate that expression of ICP27 in trans makes the
defective virus less effective at inducing apoptosis.
Inpreviouslypublishedworkfromourlaboratory,weused
a panel of mutant recombinant viruses carrying point muta-
tionsorpartialdeletionsinspeciﬁcregionsofICP27toshow
that the accumulation of early and leaky-late viral proteins
which are regulated by ICP27 correlates with the prevention
of apoptosis [35]. Taken together, these data indicate that
ICP27 itself is not responsible for the antiapoptotic activity
but rather it promotes the expression of either another vi-
ral protein(s) or a cellular factor(s) which has antiapoptotic
function during infection.
Discussion
While it is well-known that HSVs modulate apoptosis [11,
12, 46], details of the triggering and prevention mechanisms
still remain fragmented. In this report, we attempted to gain
a more global picture of what happens during HSV-1 infec-
tion. We have found that HSV-1-dependent apoptosis occurs
through the apoptosome upon translocation of Bax to mi-
tochondria, triggering of the release of cytochrome c from
mitochondria, and the subsequent activation of caspase-9
in human epithelial HEp-2 cells. Our key ﬁndings may be
summarized as follows.
HSV-1-dependent apoptosis occurs through the
mitochondrial pathway
This conclusion is based on our observation that complete
caspase-9 but not caspase-8 cleavage is detected during in-
fection with an apoptotic HSV-1 strain. Caspase-9 cleavage
duringapoptoticHSV-1infectiondirectlycorrelateswiththe
presence of other apoptotic features, such as PARP process-
ing, while caspase-3 cleavage is biphasic. Partial caspase-
3 cleavage occurs at early times following infection with
wild type HSV-1 but PARP is intact. Signiﬁcant caspase-3
cleavage is observed at later times only in cases where HSV-
1 fails to prevent apoptosis and this directly corresponds
with detectable PARP processing. We previously reported
that caspase 3 is activated at early times following infec-
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Fig. 9 ICP27 protein alone does not prevent apoptosis. HEp-2 cells
were transfected with plasmids expressing ICP27 A, B, C or simian
varicella virus ICP27 (svv27) B in the presence (+)o ra b s e n c e(−)o f
STS (A, B). (A). Cells were stained with Hoechst, ﬁxed, and prepared
forindirectimmunoﬂuoresenceusinganti-ICP27antibodyasdescribed
in materials and Methods. B. Cell extracts were prepared, separated in
a denaturing gel, transferred to nitrocellulose, and probed with anti-
PARP, -caspase-3, and -ICP27 antibodies as described in Materials
and Methods. Controls included plasmid vector only (M) transfected
cells. C. ICP27-transfected cells were infected with HSV-1(vBS 27)
(MOI = 5) and at 18 hpi, the cells were ﬁxed, prepared for indi-
rectimmunoﬂuoresenceusinganti-ICP27and-ICP22antibodies.DNA
was detected by ﬂuorescence microscopy following Hoechst staining.
Magniﬁcation (×100). Arrows mark representative cells expressing
transfected ICP27
tion with wild type virus [17] but subsequently synthesized
infected cell proteins act to inhibit the apoptotic process.
However, we cannot exclude the possibility that although
caspase 3 is activated in wild type virus-infected cells, its
activity is held in check by cellular IAPs. Since we do not
detect caspase-9 cleavage with wild type HSV-1, its partial
activation of caspase-3 likely occurs independent of apopto-
sis induction through the mitochondrial pathway. The addi-
tion of the caspase-8 inhibitor seemed to reduce caspase-3
cleavage in apoptotic HSV-1-infected cells (Fig. 3), rais-
ing the intriguing possibility that undetectable but relevant
caspase-8 activity may be involved. That caspase-8 appears
to remain inactive throughout HSV-1-dependent apoptosis
is somewhat surprising since HveA, a receptor for HSV-1,
is member of the TNF-receptor family [47]. It is therefore
conceivable that HSV-1 produces a factor that might imme-
diately preclude receptor-mediated activation of caspase-8.
Cytochrome c release from mitochondria during
HSV-1-dependent apoptosis occurs without caspase
cleavage
Theadditionofpancaspaseinhibitortocellsinfectedwithan
apoptoticHSV-1virusprecludesthedevelopmentofallovert
features of apoptosis and leads to increased accumulation of
viral polypeptides but mitochondrial cytochrome c is still re-
leased into the cytoplasm. There are at least two signiﬁcant
implications of these observations. First, these results indi-
cate that HSV-1-stimulated apoptosis is caspase-dependent.
Complete caspase-9 and caspase-3 cleavage, therefore,
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deﬁnes HSV-1-dependent apoptosis. These results are in ac-
cordancewithapreviousreportthatthereplication-defective
(ICP4- and US3-null) HSV-1(d120) virus induces apoptosis
through a caspase-dependent pathway [34] leading to cell
shrinkage, chromatin condensation, cytochrome c release,
and chromosomal DNA fragmentation in HEp-2 cells. Sec-
ond, HSV-1 induced cytochrome c release occurs in a man-
ner that does not require caspase activation. Thus, apoptotic
HSVs initiate but cannot block cytochrome c release, in-
dicating that infected cell factor(s) are required to prevent
this process. Based on these ﬁndings, one might also expect
that HSV-dependent apoptosis would only occur following
mitochondrial release of smac [48, 49] and the subsequent
decrease in levels of cellular IAPs reviewed in [50]. The
model that emerges is one in which complete caspase activa-
tion during HSV-1-dependent apoptosis is a consequence of
cytochrome c release from mitochondria. This explains the
observation that ectopic overexpression of Bcl-2 which pre-
vents cytochrome c release can decrease HSV-1-dependent
apoptosis [23]. One implication of these ﬁndings is that
cross-talk from the extrinsic to the intrinsic pathway is un-
likely to be the mechanism through which cells undergo
HSV-1-dependent apoptosis.
HSV-1 may preclude virus-induced apoptosis by targeting
proapoptotic Bax
To our knowledge, our ﬁndings represent the ﬁrst proposal
that the mechanism through which HSV-1 prevents virus-
induced apoptosis from killing infected cells is by blocking
proapoptotic Bax from relocating to mitochondria. How-
ever, there have been earlier indications that HSV-1 might
act on cellular factors to aid in the prevention of apoptosis.
It was reported that in the absence of other viral proteins, the
proapoptotic bcl-2 family member, BAD, was stabilized and
inactivated by the viral US3 kinase [27, 51]. In these studies,
caspase-3 activation and DNA fragmentation in rabbit skin
cells, triggered by infection with a baculovirus overexpress-
ing BAD (bac-BAD), was decreased after also overexpress-
ing US3 from another baculovirus vector (bac-US3). BAD
migration in acrylamide gel electrophoresis was retarded in
lysates from cells infected with bac-US3 prior to infection
withbac-BAD as compared tocontrols. Cartier et al. showed
thatoverexpressionofUS3instablecelllinescanblockHSV-
1- and chemically-induced apoptosis and prevent caspase-3
and -9 activation [52]. In these studies, when US3 is overex-
pressed, Bad is phosphorylated. Unfortunately, these results
are not without controversy. Although US3 might induce
phosphorylation of Bad in these systems, it seems that Bad
phosphorylation is dispensable for US3’s accessory [11, 12,
17]antiapoptoticfunction[53].Anothertransientexpression
study has concluded that US3 exerts its antiapoptotic effects
downstream of the mitochondria [54]. Thus, while our stud-
ies have deﬁned the point at which wild type HSV-1 blocks
virus-induced apoptosis duringproductive infection, rolesof
viral proteins, especially US3, in this process remain unre-
solved. The development of appropriate molecular genetic
and biochemical systems will be needed to address these
questions.
Conclusion
The addition of either a pancaspase inhibitor or caspase-
9-speciﬁc inhibitor prevented cells infected with an apop-
totic HSV-1 virus from undergoing cell death. Thus, HSV-
1-dependent apoptosis proceeds through the mitochondrial
apoptotic pathway. However, the pancaspase inhibitor did
not prevent the release of cytochrome c from mitochondria,
implyingthatcaspaseactivationisnotrequiredforthisinduc-
tion of apoptosis by HSV-1. Importantly, Bax accumulated
at mitochondria during apoptotic, but not wild type HSV-1
infection. These ﬁndings indicate that HSV-1 blocks apop-
tosis by precluding mitochondrial cytochrome c release in a
caspase-independent manner and suggest Bax as a target in
HSV-1-infected human epithelial cells.
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